Share

Videos

Valeant Offers to Buy Botox Maker Allergan

Bloomberg
|
April 22, 2014 AT 8:05 AM
April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Scarlet Fu reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)